Awards/COOPERATIVE AGREEMENT (B)

$41,806,723

Department of Health and Human Services·National Institutes of Health

WORK BEGAN2007-02-20·LATEST ACTION—·SOURCEUSASPENDING·SOURCE IDASST_NON_UM1AI069438_075

Award description

THE IMPACTA PERU CLINICAL TRIALS UNIT

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Supports the ongoing Impacta Peru clinical trials unit that has conducted vaccine and health research since 2007.

Sub-sectors

clinical-trials-researchvaccine-developmentnih-research

Why this matters

Long-term U.S.-Peru partnership building clinical trial capacity in a key Latin American research partner country.

Supply-chain signal

Supports downstream vaccine and therapeutic development; requires clinical supply chain, laboratory equipment, and research materials.

U.S.–China competition angle

Strengthens U.S. influence in global vaccine and therapeutic development, countering China's expanding role in health research.

Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-06-12. Cost: $0.016963.

Period of performance

Start

2007-02-20

End

2027-11-30

Status

activein 518 days

Recipient

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier ASST_NON_UM1AI069438_075.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.